Harnessing post-translational modifications for a tuberculosis booster vaccine

No­vo Nordisk is am­pli­fy­ing its ef­forts to dis­pel bias and stig­ma around obe­si­ty with two spon­sored doc­u­men­tary projects. The first is a fea­ture-length film and

A hand­ful of cash-rich phar­ma com­pa­nies have an­nounced bil­lions of dol­lars in share buy­backs in re­cent months, rais­ing ques­tions about their in­ter­est in trans­for­ma­tive deal­mak­ing